Antibody Pharmacokinetics and Pharmacodynamics
Top Cited Papers
- 1 November 2004
- journal article
- review article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 93 (11), 2645-2668
- https://doi.org/10.1002/jps.20178
Abstract
No abstract availableThis publication has 101 references indexed in Scilit:
- Pharmacokinetic/Pharmacodynamic Modeling of the Effects of Intravenous Immunoglobulin on the Disposition of Antiplatelet Antibodies in a Rat Model of Immune ThrombocytopeniaJournal of Pharmaceutical Sciences, 2003
- BasiliximabDrugs, 2003
- The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disordersNeurological Sciences, 2002
- Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First RelapseThe Journal of Clinical Pharmacology, 2001
- Interspecies Scaling of Clearance and Volume of Distribution for Digoxin-Specific FabToxicology and Applied Pharmacology, 1996
- Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis ToxicityClinical Pharmacokinetics, 1995
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Fab-bound Colchicine Appears to Adopt Fab Fragment Disposition in RatsJournal of Pharmacy and Pharmacology, 1992
- Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsEuropean Journal of Cancer and Clinical Oncology, 1991
- Past, present, and future immunotherapy of snake venom poisoningAnnals of Emergency Medicine, 1987